growing concern for health care workers (HCWs) and particularly for occupational and environmental health nurses.
For years, concerned HCW unions petitioned the Occupational Safety and Health Administration (OSHA) to develop policies specifically tailored to suit their special high risk situations. In 1983, OSHA created voluntary guidelines (emergency temporary standards) to reduce HCWs' exposure risk. After years of debate by HCWs and technical experts, the Bloodborne Pathogens Standard became an official government policy published in the Federal Register on December 6, 1991 (Barlow, 1992; Department of Labor, 1991) .
Before universal precautions were implemented, HCWs had been susceptible to contracting chronic and life threatening diseases. With the discovery of the hepatitis C virus, HCWs' concerns are once again heightened by the daily potential life threatening exposure. Unfortunately, before "universal concern" for protecting oneself, many HCWs were exposed and seroconverted to HCV antibody positive status. The seriousness of these previous exposures have yet to be fully discovered and understood due to the 10 to 30 year latent period of the virus' true virulence (Czaja, 1992) .
Hepatitis C infection and its importance to nurses in the workplace is increasing. The purpose of this article is to inform occupational and environmental health nurses about hepatitis C virus infection and treatment modalities and to assist nurses in the workplace in developing policies, procedures, and management strategies for dealing with this growing dilemma impacting HCWs.
EPIDEMIOLOGY
Worldwide, it is estimated 1% of the population is infected with the hepatitis C virus. In the United States, 1% to 2% of the general population is believed to have HCV antibodies. Hepatitis C virus is elusive. The inability to culture the virus, its ability to mutate frequently, and the fact there are over 12 serotypes have made developing a vaccine or cure impossible to date (Martin, 1995; Pawlotsky, 1995) .
In the United States, HCV is the identified agent in up to 90% of all NANB hepatitis cases and is responsible for approximately 170,000 new cases of hepatitis C annually (Consensus on HCV Testing, 1992; Marx, 1993; Weinstock, 1993) . In western countries, up to 1% of HCWs are estimated to be hepatitis C antibody positive (Alter, 1994) .
Hepatitis C virus was previously thought to be bloodborne through transfusions and needles ticks. Immune gamma globulin (IGG) was given as a treatment and as a prophylactic measure to prevent HCV transmission and conversion. The Advisory Committee on Immunization Practices (ACIP) advises against use of IGG. Immune gamma globulin is made from donated, pooled sera. It was previously believed that protective antibodies were in the IGG, hence, the "treatment of choice" for exposure to HCV. However, any "protective antibodies" are destroyed or filtered out during processing the IGG. Therefore, the risk of administering the IGG far outweighs any outside benefit one may derive. Second generation antibody testing since 1992 (second generation ELISA [enzyme linked immunosorbent assay]) of all donated blood in the United States has brought the general population's chances of contracting HCV through transfusion to a lower level than occupational exposure to HCWs (approximately 2,100 cases/per year or a 10% chance) (Lamphear, 1994; Maddrey, 1995; Rhodes, 1995) .The nurse in the workplace is in a position to educate the HCW about various modes of possible transmission and OSHA's Bloodborne Pathogens Standard.
Sources of transmission are many and varied. Of course, high risk behaviors, such as injection drug use, and multiple sexual partners, along with a high viral load of the source at the time of exposure, determine risks for transmission and seroconversion. The Sidebar on page 219 contains information about ways HCV is transmitted.
THE VIRUS
Hepatitis C is a bloodborne RNA virus from the Flaviviridae family (Rhodes, 1995) causing inflammation of the liver. The appearance of HCV RNA in blood can vary from 14 to 180 days post-exposure with an average of 45 to 55 days (Jackson, 1994; National Institutes of Health, 1997) . Seventy percent of individuals infected present 218 with no signs or symptoms (Rhodes, 1995) . Therefore, these individuals do not realize they are infected. In approximately 15%, an acute, self limiting case of hepatitis C may develop and these clients get better and clear the virus. Almost all other clients develop liver cell injury-even persons with no signs or symptoms of infection. Once infected, 85% develop chronic hepatitis. The carrier state is known to last an average of 19 years. However, some individuals remain carriers throughout their lifetime (Dawson, 1991) . Recovery is assumed if a client no longer has detectable HCV RNA in the blood and liver enzymes are normal.
Signs and symptoms of acute hepatitis C are similar to those documented in other types of acute hepatitis: • (Jackson, 1994) .
These symptoms begin to subside in 1 to 2 weeks. One fifth of all chronic carriers develop cirrhosis or chronic active hepatitis (Maddrey, 1993) . Chronic persistent and chronic active hepatitis are the two types of chronic hepatitis C that appear to be most damaging to the liver. They result in liver cell necrosis, eventually leading to liver fibrosis and, in time, liver failure. Between 8,000 to 10,000 deaths occur per year in the United States from hepatitis C (National Institutes of Health, 1997).
OSHA BLOODBORNE PATHOGENS STANDARD
The OSHA Bloodborne Pathogens Standard became effective on December 6, 1991. This federal regulation requires policies to be established (by any employer who has at least one employee with potential occupational exposure to blood and body fluids) which protect employees from blood and body fluid exposures. The nurse needs to reference this Standard as a guide when developing policies related to a safe work environment. The Standard serves as a guide to correct or prevent workplace problems should they arise. Perhaps, more importantly, the Standard should be used to assist the
Routes of ReV Transmission
Needlesticks or Other Wounds. Sources include infected scalpels, needles, or sharps previously used on HCV infected individuals. Infected tattoo needles can transmit HCV.
Hepatitis C InfectedBlood. Transmission is possible if infected blood comes In contact with an open area on skin, conjunctiva, or mucous membrane.
Intranasal Drug Use. Using "straws" that may have blood or body fluids on them to snort drugs, and then touching desiccated mucous membranes allowing for transmission of the virus.
SharingNeedles. Reuse of a syringe or needle from an infected drug user. In developing countries, reuse of improperly sterilized medical supplies (many of which are needles). Having improperly cleaned dental instruments used in the mouth. Using an infected person's used eating utensilsor toothbrush (Romero, 1990) .
Pregnancy. Pregnancy is not contraindicated for HCV infected women, but perinatal transmission can occur «6%). Breastfeeding is not contraindicated, as there is no evidence HCV is found to be transmitted in breast milk. However, experts believe infants born to HCV positive mothersshould be HCV antibodytested at 1 year of age (National Institutes of Health, 1997).
Manicures. Improperly cleaned manicure or pedicure equipment can transmit HCV (Romero, 1990) .
SexualIntercourse. Vaginal or anal sex with an infected person without use of a condom or other barrier along with a spermicidal agent (Osmond, 1993) .
Health Care Worker to Client. A physician, nurse, dentist, etc., who is infected can transmitthe virus during invasive procedures such as surgery (Fry, 1997) .
Blood Transfusions. Transfusion related HCV is extremely rare today (1 in 100,000units transfused) due to the development of the HCV second generation antibody test Maddrey, 1995) . nurse in identifying individuals at increased risk. Knowing who is truly at risk enables the nurse to formulate the proper management strategy in the form of an exposure control plan. An exposure control plan at minimum includes: • Documented exposure determination, i.e., who is at risk, • A schedule and method for implementing the plan, i.e., offering hepatitis B vaccine to all at risk employees free of charge, exposure evaluation and follow up, and inservice to all new employees, annually to all others and to everyone within 90 days of any changes noted in the FederalRegister, and . • A procedure for evaluating exposure incidents, i.e., hepatitis B vaccination and post-exposure follow up, POst-exposure lab testing free of charge for both the employee and source (Barlow, 1992; Department of Labor, 1991) . MAY 1999, VOL. 47, NO.5 The nurse must stress the importance of compliance with the exposure control plan. As an educator, the nurse in the workplace teaches: • Engineering and work place controls, • Universal precautions, and • Proper use of personal protective equipment (PPE).·
The nurse should enforce engineering controls that remove or isolate the biohazard as a routine activity in a HCW's day. Enforcement may be as simple as educating employees about proper installation as well as use and removal of sharps containers.
All HCWs should participate in and encourage workplace controls to reduce the likelihood of blood and body fluid hazards. The nurse plays an important role in reminding all HCWs, either individually or at annual inservices, about the control measures. Control measures include: • Effective handwashing technique,
• Proper handling, disposal, transportation, and sterilization of disposable and reusable sharps, .~Avoidance of eating food, drinking, smoking, applymg make up, or handling contact lenses in an area where contamination is likely, • Proper storage of food or drinks, away from potentially infectious materials, • Use of PPE during procedures where splashing, aerosolization, spraying, or splattering is likely (commonly used PPE includes: masks, gowns, face shields, glasses, goggles, shoe covers, lab coats), • Proper storage of specimens, packaging them properly for transport and applying the appropriate bio-hazard label, and • Avoidance of mouth pipetting and mouth suctioning (Barlow, 1992; Department of Labor, 1997) .
Hence, the nurse plays a vital role in ensuring the employer and employees are in compliance with the Bloodborne Pathogens Standard. The nurse in the workplace is often the first line of defense against the hepatitis C virus and all other potentially infectious pathogens.
ADMINISTRATIVE CONTROLS
Among the nurse's management strategies in preventing HCV transmission is to implement changes with the use of safer medical devices, such as the use of needleless infusion systems throughout the workplace. The nurse in the workplace has the responsibility to provide workers with continuing education classes about the use of PPE, along with bloodborne pathogens and universal precautions inservices. Any PPEmust be provided, maintained, and replaced when appropriate by the employer without charge to the employee. Hypoallergenic PPE should be provided as necessary. Education needs to be initiated at the workplace orientation. The exposure control plan should be reviewed annually, updated as necessary, and presented to all employees at yearly inservices. The nurse can encourage the use of peer pressure to enforce precautions and adherence to administrative policies.
BLOOD/BODY FLUID EXPOSURE-NURSING ROLE
Exposure to blood and body fluids still occurs despite correct use of PPE and adherence to strict uni-. versal precautions. The nurse not only needs to treat the HCW's physical injury, e.g., eyesplash or needles tick, but.also the "psychological" injury (anxiety about blood test results of self and source, effect of exposure on personallife).
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Treating the Injury
Upon a percutaneous exposure, the site should be made to bleed more, thereby cleansing the wound tract from the "inside out." This act theoretically flushes any macro-or microscopic contamination from the wound. Once this is accomplished, the area needs to be cleansed with soap (preferably antibacterial for cleansing purposes only) and water, iodine solution (Betadine), hydrogen peroxide, or even isopropyl alcohol. The cleansing is followed by administration of an anti-bacterial cream, ointment, spray, or gel and applying a sterile dressing. It is important to point out none of these solutions or topical agents kills the human immunodeficiency virus (HIV) or the hepatitis B virus. Many of the agents that do kill these viruses are caustic to the skin.
If the blood and/or body fluid exposure is a splash that occurs to intact skin or mucous membrane, the site should be rinsed with copious amounts of clean water and/or cleansed with soap and water. If the exposure occurs to an eye, it is important to flush it with copious amounts of water and evaluate the need for an ophthalmology consultation. Conditions that may require consultation are an irritated eye, corneal abrasion, or a chemical exposure. Prompt and proper health care (sutures, Steri-Strips, antibacterial ointment, sterile dressing, tetanus-diphtheria prophylaxis, etc.) should be provided along with counseling. Bloodborne pathogens training, including knowledge about the Bloodborne Pathogens Standard, qualifies the nurse to counsel the employee.
Counseling
Counseling cannot be overemphasized. All counseling for HCW exposure needs to include an explanation of potential risks for seroconversion for the particular blood and body fluid exposure that occurred (type of fluid, route of transmission). It is crucial to ensure that HCWs thoroughly understand possible routes of transmission to other individuals because they have now become a possible exposure source. Protecting other individuals until the HCW has completed exposure follow up and found to be noninfectious includes abstention from intercourse; use of condomslbarriers (during sex of any kind), along with spermicidal jelly/cream during intercourse: and avoidance of blood, organ, sperm, or tissue donation or breastfeeding. Follow up care does not need to extend beyond 6 months because HCV antibody can be detected in serum as early as 1 to 3 weeks post-conversion . (National Institutes of Health, 1997 ). An explanation of the follow up process, such as follow up dates, lab work, medication, vaccination schedule, and an infectious disease consultation, if indicated, should be addressed. Most importantly, written information needs to be provided to the HCW including all the aforementioned.
The post-exposure process is very stressful. The exposed employee mayor may not hear or process everything. Written information helps increase the likelihood this important material is understood, processed, and maintained. It also allows the HCW the opportunity to review the material as many times as necessary. 
Testing
Education and Prevention
The nurse in the workplace needs to stress the importance of reporting any and all blood and body fluid exposures no matter how "low risk" they may seem. Opportunities to emphasize this point are at new employee orientation and/or mandatory inservice. A clearly articulated post-exposure blood and body fluid protocol helps facilitate movement of the HCW through the exposure process quickly and smoothly and can help to prevent additional stress and anxiety. Strict confidentiality must be maintained not only to gain HCW trust, but also to prevent underreporting of blood and body fluid exposures.
The nurse must be well informed about all aspects of a bloodlbody fluid exposure, from initial treatment to counseling and follow up care. Each exposure incident should be explored and followed up thoroughly for causation, correction, and prevention of further incidents. It is important for the nurse to assess units with multiple exposures to see if a problem exists with equipment, e.g., needlebox malfunction, or if HCW behavior modification is needed to correct dangerous habits or bad prac- MAY 1999, VOL. 47, NO.5 tices, such as recapping needles or improper handling of medical waste. Suggestions for correcting the unsafe situation need to be offered by the occupational or environmental health nurse. In some cases, principles of risk management need to be addressed to ensure an immediate response to the exposure hazard. Lastly, the nurse should assess and obtain information about the employee's knowledge or lack of knowledge related to blood and body fluid exposures and their prevention.
TREATMENT AND CURE
Unfortunately, HCV is not curable. Health care workers do become exposed and seroconvert. Treatment of the acute phase is symptomatic and centers on client comfort. Interferon and ribavirin therapy may be used, but only in clients with persistent SGPT elevations, positive HCV RNA, a liver biopsy showing portal or bridging fibrosis, and at least moderate degrees of inflammation and necrosis (National Institutes of Health, 1997). If cirrhosis has already begun to develop, interferon and ribavirin therapy is usually not as effective. Based on comparison of the pre-treatment and post-treatment liver biopsies, the client's need for future treatments if any, or possible work up for liver transplant can be assessed. Other treatments used or under clinical trials are quanosine analogues, protease inhibitors, interleukin, and liver transplant.
CONCLUSION
The hepatitis C virus is a spreading and thus an emerging dilemma for the nurse. Because there is no vaccine or cure, the focus of the nurse's management strategy must be prevention. By educating HCWs about the virus, universal precautions, PPE, and measures to make the working environment safer, the risk for occupational transmission is decreased. When an exposure has occurred, the nurse has a central role in ensuring the HCW's blood and body fluid exposure work up and follow up care is handled with knowledge, trust, professionalism, and empathy.
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Occupational health nurses have the responsibility to educate their clients about hepatitis C as a growing public health threat.
Occupational health nurses have the responsibility to keep their clients up to date on the latest treatment modalities.
Occupational health nurses practice in a framework from which to establish policies and procedures to treat blood and body fluid exposures.
Author's Note: Although the October 16, 1998 MMWR "Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-Related Chronic Disease" are widely used by occupational health professionals working in the health care/medical center environment, the 1997 NIH consensus statement on which the MMWR recommendations are based is considered to be more comprehensive and are the recommendations cited in this article. It is important to note that the MMWR recommendations are outdated regarding treatment, as combination interferonlribavirin treatment has now been approved for use in patients not previously treated.
